• How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

  • Aug 9 2024
  • Length: 25 mins
  • Podcast

How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

Listen for free

View show details

  • Summary

  • During the Psoriasis Hub Steering Committee Meeting in May 2024, key opinion leaders met to discuss the current treatment landscape for patients with psoriasis and PsA.

    The recorded discussion was chaired by Paolo Gisondi, and featured Alice Gottlieb and Yukari Okubo. The steering committee discussed recent approvals of systemic agents for psoriatic disease, including efficacy and safety data of bimekizumab and deucravacitinib. They also spoke about how to avoid and treat oral candidiasis infections in patients treated with interleukin 17 inhibitors.


    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about How do recent systemic approvals influence treatment selection for patients with psoriatic disease?​

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available